Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
| Status: | Completed |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 1/25/2018 |
| Start Date: | July 2004 |
| End Date: | August 2004 |
A Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fasting Conditions
The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under
fasted conditions
fasted conditions
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C.
- Treatment with known enzyme altering drugs.
- History of allergic or adverse response to exemestane or any comparable or similar
product.
We found this trial at
1
site
Click here to add this to my saved trials
